Lung cancer screening in people living with HIV: modeling to bridge the evidence.
作者信息
Robbins Hilary A
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
出版信息
AIDS. 2018 Jun 19;32(10):1369-1371. doi: 10.1097/QAD.0000000000001819.
Abstract
摘要
相似文献
1
Lung cancer screening in people living with HIV: modeling to bridge the evidence.HIV感染者的肺癌筛查：建立证据的模型构建
AIDS. 2018 Jun 19;32(10):1369-1371. doi: 10.1097/QAD.0000000000001819.
2
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.在 CD4+ 细胞计数至少为 500 个/μl 的 HIV 感染者中进行肺癌筛查的益处和危害。
AIDS. 2018 Jun 19;32(10):1333-1342. doi: 10.1097/QAD.0000000000001818.
3
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.美国 HIV 感染者肺癌的免疫和感染危险因素：一项纵向队列研究。
Lancet HIV. 2017 Feb;4(2):e67-e73. doi: 10.1016/S2352-3018(16)30215-6. Epub 2016 Dec 2.
4
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.基于即时检测C反应蛋白的HIV感染者结核病筛查：一项诊断准确性研究。
Lancet Infect Dis. 2017 Dec;17(12):1285-1292. doi: 10.1016/S1473-3099(17)30488-7. Epub 2017 Aug 25.
5
Incidence of cancer in people living with HIV and prognostic value of current CD4.HIV感染者的癌症发病率及当前CD4的预后价值
Bull Cancer. 2019 Mar;106(3):201-205. doi: 10.1016/j.bulcan.2018.11.003. Epub 2018 Nov 29.
6
[Clinical features of lung cancer HIV-infected patients].[HIV感染肺癌患者的临床特征]
Nihon Kokyuki Gakkai Zasshi. 2007 Sep;45(9):661-6.
7
CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.CD4细胞计数：抗逆转录病毒治疗资格的递减值。
Clin Infect Dis. 2016 Apr 15;62(8):1022-8. doi: 10.1093/cid/civ1224. Epub 2016 Jan 29.
8
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.1997年至2009年间法国HIV-1感染者中非艾滋病定义性癌症的风险：一项法国队列研究的结果
AIDS. 2014 Sep 10;28(14):2109-18. doi: 10.1097/QAD.0000000000000382.
9
Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening.肺气肿和可溶性CD14与HIV感染患者的肺结节相关：对肺癌筛查的意义
AIDS. 2017 Jul 31;31(12):1715-1720. doi: 10.1097/QAD.0000000000001529.
10
A proposal for basic management of HIV disease in west Africa: use of clinical staging and haemogram data.西非艾滋病基本管理建议：临床分期及血常规数据的应用
Int J STD AIDS. 1998 Aug;9(8):463-70. doi: 10.1258/0956462981922638.
引用本文的文献
1
Lung cancer screening adherence among people living with and without HIV: An analysis of an integrated health system in Florida, United States (2012-2021).感染与未感染艾滋病毒人群的肺癌筛查依从性：对美国佛罗里达州一个综合卫生系统的分析（2012 - 2021年）
Prev Med Rep. 2023 Jul 21;35:102334. doi: 10.1016/j.pmedr.2023.102334. eCollection 2023 Oct.
2
Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.HIV 阴性和 HIV 感染幸存者霍奇金淋巴瘤治疗后的第二原发恶性肿瘤风险。
Leuk Lymphoma. 2022 May;63(5):1091-1101. doi: 10.1080/10428194.2021.2020775. Epub 2022 Jan 6.
本文引用的文献
1
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.在 CD4+ 细胞计数至少为 500 个/μl 的 HIV 感染者中进行肺癌筛查的益处和危害。
AIDS. 2018 Jun 19;32(10):1333-1342. doi: 10.1097/QAD.0000000000001818.
2
Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.癌症归因死亡率在北美的治疗人类免疫缺陷病毒感染的人群中。
Clin Infect Dis. 2017 Aug 15;65(4):636-643. doi: 10.1093/cid/cix392.
3
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.1996 年至 2013 年开始抗逆转录病毒治疗的 HIV 阳性患者的生存情况：队列研究的协作分析。
Lancet HIV. 2017 Aug;4(8):e349-e356. doi: 10.1016/S2352-3018(17)30066-8. Epub 2017 May 10.
4
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.HIV感染、免疫抑制与非艾滋病定义性癌症诊断时的年龄
Clin Infect Dis. 2017 Feb 15;64(4):468-475. doi: 10.1093/cid/ciw764.
5
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.美国 HIV 感染者肺癌的免疫和感染危险因素：一项纵向队列研究。
Lancet HIV. 2017 Feb;4(2):e67-e73. doi: 10.1016/S2352-3018(16)30215-6. Epub 2016 Dec 2.
6
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.用于选择曾经吸烟者进行CT肺癌筛查的风险模型的开发与验证
JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.
7
Human immunodeficiency virus transmission at each step of the care continuum in the United States.美国关爱连续体各环节中的人类免疫缺陷病毒传播。
JAMA Intern Med. 2015 Apr;175(4):588-96. doi: 10.1001/jamainternmed.2014.8180.
8
Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening.无症状HIV感染患者胸部计算机断层扫描检查结果：对肺癌筛查的意义
AIDS. 2014 Apr 24;28(7):1007-14. doi: 10.1097/QAD.0000000000000189.
9
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.计算机断层扫描肺癌筛查策略的利弊：美国预防服务工作组的比较建模研究。
Ann Intern Med. 2014 Mar 4;160(5):311-20. doi: 10.7326/M13-2316.
10
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.人类免疫缺陷病毒感染作为非小细胞肺癌手术患者的预后因素。
Ann Thorac Surg. 2012 Feb;93(2):405-12. doi: 10.1016/j.athoracsur.2011.11.012.
Zotero 插件